Literature DB >> 7825586

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

S A Narod1, D Ford, P Devilee, R B Barkardottir, H T Lynch, S A Smith, B A Ponder, B L Weber, J E Garber, J M Birch.   

Abstract

The breast-ovary cancer-family syndrome is a dominant predisposition to cancer of the breast and ovaries which has been mapped to chromosome region 17q12-q21. The majority, but not all, of breast-ovary cancer families show linkage to this susceptibility locus, designated BRCA1. We report here the results of a linkage analysis of 145 families with both breast and ovarian cancer. These families contain either a total of three or more cases of early-onset (before age 60 years) breast cancer or ovarian cancer. All families contained at least one case of ovarian cancer. Overall, an estimated 76% of the 145 families are linked to the BRCA1 locus. None of the 13 families with cases of male breast cancer appear to be linked, but it is estimated that 92% (95% confidence interval 76%-100%) of families with no male breast cancer and with two or more ovarian cancers are linked to BRCA1. These data suggest that the breast-ovarian cancer-family syndrome is genetically heterogeneous. However, the large majority of families with early-onset breast cancer and with two or more cases of ovarian cancer are likely to be due to BRCA1 mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7825586      PMCID: PMC1801289     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  37 in total

1.  Allele loss on chromosome 17q in sporadic ovarian cancer.

Authors:  W Foulkes; D Black; E Solomon; J Trowsdale
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

2.  Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci.

Authors:  J L Weber; A E Kwitek; P E May; M R Wallace; F S Collins; D H Ledbetter
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

3.  Closing in on a breast cancer gene on chromosome 17q.

Authors:  J M Hall; L Friedman; C Guenther; M K Lee; J L Weber; D M Black; M C King
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

4.  Familial breast-ovarian cancer locus on chromosome 17q12-q23.

Authors:  S A Narod; J Feunteun; H T Lynch; P Watson; T Conway; J Lynch; G M Lenoir
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

5.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

6.  Analysis of 138 consecutive ovarian cancer patients: incidence and characteristics of familial cases.

Authors:  S Greggi; M Genuardi; P Benedetti-Panici; R Cento; G Scambia; G Neri; S Mancuso
Journal:  Gynecol Oncol       Date:  1990-12       Impact factor: 5.482

7.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

8.  Genetic heterogeneity of early-onset familial breast cancer.

Authors:  H Sobol; S Mazoyer; S A Narod; S A Smith; D M Black; P Kerbrat; B Jamot; E Solomon; B A Ponder; D Guerin
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

9.  BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis.

Authors:  J S Chamberlain; M Boehnke; T S Frank; S Kiousis; J Xu; S W Guo; E R Hauser; R A Norum; E A Helmbold; D S Markel
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

10.  The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12-q21.

Authors:  P Tonin; O Serova; J Simard; G Lenoir; J Feunteun; K Morgan; H Lynch; S Narod
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

View more
  67 in total

1.  A highly accurate, low cost test for BRCA1 mutations.

Authors:  N J van Orsouw; R K Dhanda; Y Elhaji; S A Narod; F P Li; C Eng; J Vijg
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

2.  The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.

Authors:  J F Stratton; D Thompson; L Bobrow; N Dalal; M Gore; D T Bishop; I Scott; G Evans; P Daly; D F Easton; B A Ponder
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 3.  Heterogeneity and the genetics of autism.

Authors:  P Szatmari
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

Review 4.  Forth nightly review: hereditary ovarian carcinoma.

Authors:  L Kasprzak; W D Foulkes; A N Shelling
Journal:  BMJ       Date:  1999-03-20

5.  Reading between the lines: direct-to-consumer advertising of genetic testing.

Authors:  S C Hull; K Prasad
Journal:  Hastings Cent Rep       Date:  2001 May-Jun       Impact factor: 2.683

6.  Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.

Authors:  L J Huber; T W Yang; C J Sarkisian; S R Master; C X Deng; L A Chodosh
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 7.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

8.  Interactions between genetic and reproductive factors in breast cancer risk in a French family sample.

Authors:  N Andrieu; F Demenais
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

9.  Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.

Authors:  F Durocher; P Tonin; D Shattuck-Eidens; M Skolnick; S A Narod; J Simard
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

10.  High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.

Authors:  Banu Arun; Kristen J Vogel; Adriana Lopez; Mike Hernandez; Deann Atchley; Kristine R Broglio; Christopher I Amos; Funda Meric-Bernstam; Henry Kuerer; Gabriel N Hortobagyi; Constance T Albarracin
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.